Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Miosis Inhibition in Vitreoretinal Surgery
NCT00576329Phase 3Completed
- Sponsor
- Emory University
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in miosis comparing Placebo with Ketorolac (2 arms). Primary endpoint: Change in pupil size during vitreoretinal surgery. Started Nov 2006; status: completed.
02
Drugs
ketorolac
03
Conditions
miosis
Beyond the preview
Go deeper on NCT00576329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576329.